Assassin's Creed Shadows may fill the void left by the absence of a new Splinter Cell game, offering stealth gameplay fans a new experience. Based on its recent gameplay reveal, Assassin's Creed ...

It feels like the Splinter Cell remake has been on its way for a decent ... to be aiming to rebuild the stealth game for an all-new audience without straying too far from the source material.

Fans have been waiting for new Splinter Cell content for years ... around since 2002 and are a staple within the stealth ...

So we've kinda been waiting for a few weeks to see […] Rumor: A New "Splinter Cell" Item Hints At New Game If you believe the rumor mill this week, it looks like Ubisoft are planning the next ...

The remake aims to revitalize the franchise and breathe new life into the stealth action genre. Players looking forward to seeing Ubisoft's current-generation remake of Tom Clancy's Splinter Cell ...

A new Splinter Cell game was sorely missing from the Ubisoft ... Highly interactive environments giving players more gameplay options and the ability to strategize their actions.

Ubisoft still hasn’t revealed any new information ... ‘modernised stealth gameplay, while preserving what’s at the heart of the Splinter Cell experience.’ Although these descriptions ...

At last, Fisher finds himself at the White House, and things are looking pretty grim. Somewhere beyond the Black Arrow patrols and perimeters, through the blood soaked halls of the Oval Office ...

Some great games have been forged in this mold, but Into The Dead: Our Darkest Days, developed by New Zealand indie studio ... feels a bit like a bygone Splinter Cell adventure, where deterrence ...

At last, Fisher finds himself at the White House, and things are looking pretty grim. Somewhere beyond the Black Arrow patrols and perimeters, through the blood soaked halls of the Oval Office ...

Cell therapy biotech Tolerance Bio has unveiled with $17.2 million and a mission of targeting immune diseases by stretching and saving the function of a key organ. The Philadelphia biotech’s ...